Current and prospective treatments for multidrug-resistant gram-positive infections
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and prospective treatments for multidrug-resistant gram-positive infections
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 14, Pages 1919-1932
Publisher
Informa Healthcare
Online
2013-07-22
DOI
10.1517/14656566.2013.820276
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA
- (2013) B. J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents
- (2012) Michelle L Campbell et al. ANNALS OF PHARMACOTHERAPY
- Evaluation of the Novel Combination of High-Dose Daptomycin plus Trimethoprim-Sulfamethoxazole against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Using anIn VitroPharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations
- (2012) Molly E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in anIn VitroPharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2012) Ashley D. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers
- (2012) Seth T. Housman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis
- (2012) José M. Miró et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
- (2012) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment
- (2012) Pamela A. Moise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects
- (2012) Keith A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates
- (2012) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
- (2012) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid
- (2012) Elena M. Santayana et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Tedizolid (TR-701): a new oxazolidinone with enhanced potency
- (2012) Zeina A. Kanafani et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004–2010
- (2012) Stephen P. Hawser et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers
- (2012) Martina Sahre et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
- (2012) S. N. Leonard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline
- (2012) R. E. Mendes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy
- (2012) T. T. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients
- (2012) Jennifer C. Lin et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains
- (2012) Viviana Cafiso et al. PLoS One
- Synergy between Vancomycin and Nafcillin against Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
- (2012) Steven N. Leonard PLoS One
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- In VivoPharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus
- (2011) Mao Hagihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Activity versus Daptomycin (DAP) against DAP-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strains in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Molly Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008
- (2011) D. A. Talan et al. CLINICAL INFECTIOUS DISEASES
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
- (2011) R. Kullar et al. CLINICAL INFECTIOUS DISEASES
- In vitro time–kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin
- (2011) Céline Vidaillac et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution
- (2011) Mini Kamboj et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
- (2011) I. Rodriguez-Avial et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates
- (2011) S. J. van Hal et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
- (2011) Ravina Kullar et al. PHARMACOTHERAPY
- Successful Treatment of Vancomycin-Intermediate Staphylococcus aureus Pacemaker Lead Infective Endocarditis with Telavancin
- (2010) L. A. Marcos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations
- (2010) M. E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin
- (2010) C. M. Hill et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
- (2010) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Linezolid Is Mediated by thecfrGene in the First Report of an Outbreak of Linezolid‐ResistantStaphylococcus aureus
- (2010) Gracia Morales et al. CLINICAL INFECTIOUS DISEASES
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians
- (2010) T. Kelesidis et al. CLINICAL INFECTIOUS DISEASES
- Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study
- (2010) Christopher W. Crank et al. CLINICAL THERAPEUTICS
- Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results
- (2010) Shannon D. Putnam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
- (2010) Shannon D. Putnam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
- (2010) Miguel Sánchez García JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials
- (2010) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin Susceptibility Trends and Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Clinical Methicillin-Resistant S. aureus Isolates
- (2010) A. M. Pitz et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia
- (2009) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates from 14 Cities in China
- (2009) W. Sun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital
- (2009) Rosa Gómez-Gil et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)
- (2009) John F. Mohr et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- (2009) Nikos Roussos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid
- (2009) Abdullah Balkhair et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
- (2009) G. A. McKay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals
- (2009) H. S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment
- (2009) Thomas Marbury et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
- (2009) Pamela A Moise et al. LANCET INFECTIOUS DISEASES
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
- (2008) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
- (2008) D. M. Sievert et al. CLINICAL INFECTIOUS DISEASES
- Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)
- (2008) M. J. Rybak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Co-opting the Cell Wall in Fighting Methicillin-ResistantStaphylococcus aureus: Potent Inhibition of PBP 2a by Two Anti-MRSA β-Lactam Antibiotics
- (2008) Adriel Villegas-Estrada et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started